子宫内膜异位症是否增加子宫内膜增生和子宫内膜癌的风险
这项基于韩国国民健康保险数据库的全国性人群观察性研究纳入2002至2017年确诊子宫内膜异位症的147,869名女性,每名患者匹配20名无子宫内膜异位症对照。校正协变量后,子宫内膜异位症女性子宫内膜增生风险显著升高(aHR 1.85,95%CI 1.75-1.95),子宫内膜癌风险亦显著升高(aHR 1.35,95%CI 1.12-1.63);子宫内膜异位症诊断不影响子宫内膜癌患者生存。
要点
- 子宫内膜异位症女性子宫内膜增生风险显著升高(aHR 1.85,95%CI 1.75-1.95)。
- 子宫内膜异位症女性子宫内膜癌风险显著升高(aHR 1.35,95%CI 1.12-1.63)。
- 子宫内膜异位症诊断不影响子宫内膜癌患者的生存。
核心结论
- 子宫内膜异位症女性的子宫内膜增生和子宫内膜癌风险均显著高于无子宫内膜异位症女性。
- 子宫内膜异位症的存在不影响子宫内膜癌女性的总生存。
- 需要进一步开展充分控制混杂因素的长期前瞻性研究。
研究设计与样本
- 全国性人群观察性研究,分析韩国国民健康保险数据库数据。
- 纳入2002至2017年确诊子宫内膜异位症的147,869名女性,每名患者匹配20名无子宫内膜异位症对照女性。
- 采用Cox比例风险回归分析估计子宫内膜增生、子宫内膜癌及子宫内膜癌死亡的风险比(HR)。
主要发现
- 该人群三百万女性中,随访19,931,794人年期间,16,377名女性诊断为子宫内膜增生,1,795名女性诊断为子宫内膜癌。
- 校正协变量后,子宫内膜异位症女性较对照女性子宫内膜增生风险显著升高(aHR 1.85,95%CI 1.75-1.95)。
- 校正协变量后,子宫内膜异位症女性较对照女性子宫内膜癌风险显著升高(aHR 1.35,95%CI 1.12-1.63)。
- 子宫内膜异位症诊断不影响子宫内膜癌患者的生存。
局限性
- 需要进一步开展充分控制混杂因素的长期前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of developing endometrial hyperplasia after diagnosis of endometriosis has not been determined. Moreover, the risk of endometrial cancer associated with endometriosis is unclear. This nationwide population-based study investigated the associations of endometrial hyperplasia and endometrial cancer with endometriosis, after adjusting for covariates. METHODS: This population-based observational study analyzed data from the Korean National Health Insurance (NHI) database, including 147,869 women who were diagnosed with endometriosis from 2002 to 2017, with each patient matched to 20 control women without endometriosis. Cox proportional hazard regression analyses were performed to estimate the hazard ratios (HRs) of endometrial hyperplasia, endometrial cancer, and mortality from endometrial cancer. RESULTS: Among three million women in this population, 16,377 women were diagnosed with endometrial hyperplasia, and 1795 women were diagnosed with endometrial cancer over 19,931,794 person-years of follow-up. Women with endometriosis were at significantly higher risks of endometrial hyperplasia (adjusted hazard ratio [aHR] 1.85, 95% confidence interval [CI] 1.75-1.95), and endometrial cancer (aHR 1.35, 95% CI 1.12-1.63) were compared with control women after adjustment for covariates. A diagnosis of endometriosis did not affect survival in patients with endometrial cancer. CONCLUSION: The risks of endometrial hyperplasia and endometrial cancer were found to be significantly higher in women with than without endometriosis. The presence of endometriosis did not affect overall survival in women with endometrial cancer. Additional long-term prospective studies with adequate control of confounders are needed.
引用
- Kim H, Kim HJ, Ahn HS, et al. Does endometriosis increase the risks of endometrial hyperplasia and endometrial cancer? Gynecol Oncol. 2022. PMID: 36357191. doi:10.1016/j.ygyno.2022.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。